Clinical Trials Logo

Amyloid Neuropathies, Familial clinical trials

View clinical trials related to Amyloid Neuropathies, Familial.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04882735 Withdrawn - Clinical trials for Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

Efficacy and Safety of Acoramidis (AG10) in Subjects With Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)

Start date: September 2021
Phase: Phase 3
Study type: Interventional

Phase 3 efficacy and safety of acoramidis in subjects with symptomatic Transthyretin Amyloid Polyneuropathy (ATTR-PN)

NCT ID: NCT04418024 Withdrawn - Clinical trials for Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Polyneurophathy

ATTRibute-PN
Start date: October 21, 2020
Phase: Phase 3
Study type: Interventional

See updated study design under NCT04882735. Phase 3 efficacy and safety of AG10 compared with placebo in subjects with symptomatic Transthyretin Amyloid Polyneuropathy (ATTR-PN)

NCT ID: NCT02713880 Withdrawn - Clinical trials for Transthyretin Amyloidosis

Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP)

BioTRAP
Start date: August 20, 2018
Phase:
Study type: Observational

International, multicenter, observational, longitudinal study to identify biomarker/s for the development of a new MS-based biomarker for the early and sensitive diagnosis of Transthyretin-Related Familial Amyloidotic Polyneuropathy from blood and number of correctly identified patients with Transthyretin-Related Familial Amyloidotic Polyneuropathy